Valentrifect™ Stem

iPSC transfection with low stress.

A drop-in replacement for today’s lipid reagents in induced pluripotent stem cells: the same workflow, with much more expression, and cells that stay pluripotent.

1.5× to 30×more GFP-positive cells across six human iPSC linesvs. Lipofectamine™ Stem
6 of 6iPSC lines with higher expression than Lipofectamine™ Stem, at low and high ends of the recommended reagent levelsn = 4 biological replicates
100%pluripotency maintained after transfection, and cells still differentiate to mesoderm and ectodermIndependent testing by Forte Biosciences
Performance data

Higher expression in every iPSC line we tested.

GFP expression measured side by side with Lipofectamine™ Stem: in highly optimized WTC11 culture at the Marcus Center, and across six iPSC lines at Forte Biosciences, averaged over a wide range of culture conditions.

Valentrifect™ StemLipofectamine™ Stem
WTC11 hiPSCs · Highly optimized culture conditions · % GFP-positive cells at 24 hMarcus Center of Excellence for Cell Biomanufacturing
GFP mRNA95631.5×
Plasmid DNA192.09.5×
Six human iPSC lines · GFP mRNA · Lower Reagent Levels · % GFP-positive cells at 24 hAveraged over a wide range of culture conditions · Forte Biosciences
KOLF.258.81.9629.9×
GM2897844.51.8723.8×
WTC-1125.91.8713.9×
IPSC802-3G20.81.6712.4×
GM2840416.31.6110.1×
IPS20714.51.778.2×
Six human iPSC lines · GFP mRNA · Higher reagent levels · % GFP-positive cells at 24 hAveraged over a wide range of culture conditions · Forte Biosciences
GM2897857.69.316.2×
WTC-1138.47.035.5×
KOLF.268.116.134.2×
GM2840427.37.263.8×
IPSC802-3G26.67.353.6×
IPS20715.86.902.3×
Pluripotency & differentiability

Transfected iPSCs stay pluripotent and can still differentiate.

Transfected iPSCsGFP-positive cells after Valentrifect™ Stem mRNA delivery

Core pluripotency factors retained

OCT4SOX2NANOG

No shift vs. untransfected controls and no spontaneous differentiation, the same result as Lipofectamine™ Stem.

Mesoderm

100%

of GFP-positive cells differentiated to mesoderm.

NCAMBrachyury

Ectoderm

Observed

GFP-positive cells differentiated to ectoderm (abbreviated protocol).

PAX6Nestin

Pluripotency by flow cytometry (OCT4, SOX2, NANOG) in GFP-positive cells; lineage markers by flow cytometry after directed differentiation.

Run 1 is at the low end of the reagent concentration range specified for both Valentrifect™ Stem and Lipofectamine™ Stem; Run 2 is at the high end. Marcus Center values are mean ± 2 percentage points; plasmid DNA expression is still developing at 24 h. Each pair is scaled on its own, so bar length compares Valentrifect™ Stem with Lipofectamine™ Stem within that cell line and run, not between them; the numbers on the bars are percent GFP-positive cells. WTC11 measurements by the Marcus Center of Excellence for Cell Biomanufacturing; the six-line comparison by Forte Biosciences.

Cell health

Gentle on cells. Strong on expression.

  • Cell viability above 90% in all conditions tested.
  • No interferon or stress response at 6 h or 24 h across five marker genes, matching untreated cells and Lipofectamine™ Stem.
  • OCT4, SOX2 and NANOG retained in GFP-positive cells, with no shift versus untransfected controls and no spontaneous differentiation.
  • Transfected cells still differentiate on demand: 100% of GFP-positive cells differentiated to mesoderm, and ectoderm differentiation was also observed (abbreviated protocol).

Independent testing by Forte Biosciences, including viability. KOLF2 hiPSCs transfected with GFP mRNA; RT-qPCR for stress markers; flow cytometry for pluripotency (OCT4, SOX2, NANOG) and, after directed differentiation, lineage markers.

At a glance

What you get.

ApplicationiPSC transfection
PayloadsmRNA, plasmid DNA, self-amplifying RNA
Particle size80 ± 5 nm
StabilityRoom temperature for 15+ days; 4 °C for 1 year
UseResearch use only
Free evaluation sample

See it in your own iPSCs.

We provide evaluation samples so you can compare Valentrifect™ Stem with your current reagent at your own bench.

For research use only. Not for diagnostic or therapeutic use. Lipofectamine™, MessengerMAX™ and ExpiFectamine™ are trademarks of Thermo Fisher Scientific, which is not affiliated with Valentris.